[FG] Brühl Annette

At the ECANL (Experimental Cognitive Affective Neuroscience Lab) we investigate mechanisms of depression disease and its treatments with the aim of improving treatments. Currently, we focus on electroconvulsive therapy (ECT) as a highly efficacious but not fully understood method. We are establishing a multicentre digital database of treatment parameters and outcomes. We use EEG to characterize the therapeutic seizure and polysomnography to reveal the association between sleep and ECT, and stool samples to investigate the effect of ECT on the gut microbiome.